cemka > Publications > Pharmaco-Epidémiologie

Classer les publications sur l'année

  • Pharmaco-Epidémiologie

    Vitiligo Patient Population and Disease Burden in France: VIOLIN Study Results From the CONSTANCES Cohort.

    EZZEDINE K, SENESCHAL J, DA SILVA A, PREAUBERT N, LAMBLIN A, DELATTRE C, EMERY C, NEVORET C, FINZI J, BOUEE S, PASSERON T.

    J Eur Acad Dermatol Venereol ; 2023;7 : 2159–2160

  • Pharmaco-Epidémiologie

    Treatment Patterns and Survival in Patients with Intermediate, Advanced, or Terminal Stage of Hepatocellular Carcinoma in France over the Period 2015-2017: A Real-Life Study

    BLANC J-F, LAURENDEAU C, DE ZELICOURT M, DHAOUI M, KELKOULI N, FAGNANI F, MATHURIN P.

    GastroHep ; 2023; Article ID 5800168, 12 pages

  • Pharmaco-Epidémiologie

    Point-of-Care Testing for SARS-CoV-2 : A Prospective Study in a Primary Health Centre

    DANIELS R, COTTIN J, KHANAFER N

    Diagnostics ; 2023;13(11):1888

  • Pharmaco-Epidémiologie

    Asthma burden according to treatment steps in the French population-based cohort CONSTANCES.

    ROCHE N, NADIF R, FABRY-VENDRAND C, PILLOT L, THABUT G, TEISSIER C, BOUEE S, GOLDBERG M, ZINS M.

    Respir Med ; 2023;206:107057

  • Pharmaco-Epidémiologie

    Medico-economic comparison of two anticoagulant treatment strategies: Vitamin K antagonists vs. direct oral anticoagulants in older adults in nursing homes in France. The « MIKADO » study

    PISICA-DONOSE G, PICCOLI M, GENET B, BOUEE S, BERECHET S, BERECHET I, DACASA CORTES A, ATSAMENA S, BAYLE C, BADESCU M, CATELAIN F, KERMECHE L, MERLIER I, RAKOTONIARY S, SAVIN V, VIDAL A, VIDAL J-S, HANON O.

    PLoS One  ; 2023;18(4):e0283604

  • Pharmaco-Epidémiologie

    The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus.

    DE SEZE J, SUCHET L, MEKIES C, MANCHON E, LABAUGE P, GUENNOC AM, DEFER G, CLAVELOU P, CASTELNOVO G, BOURRE B, BENSA-KOSCHER C, AL KHEDR A, LE MAO J, VILLEMUR L, BOUEE S, LUCIANI L, VERMERSCH P.

    Neurol Ther ; 2023;12(2):351-369

  • Pharmaco-Epidémiologie

    Lipid-lowering efficacy and safety of alirocumab in a real-life setting in France: insights from the ODYSSEY APPRISE study.

    HENRY P, CARIOU B, FARNIER M, LAKHDARI SL, DETOURNAY B.

    Arch Cardiovasc Dis ; 2023;116(1):3-8

  • Pharmaco-Epidémiologie

    Quality of life in SSc-ILD patients: Understanding the impact of the ILD and the needs of the SSc-ILD patients and their need for caregivers in France.

    ALLANORE Y, CONSTANS J, GODARD D, DE POUVOURVILLE G, BOUEE S, JEANBAT V, TEISSIER C, LE LAY K, CHOLLET J, HACHULLA E.

    J Scleroderma Related Disorders ; 2022;7(1):49-56

  • Pharmaco-Epidémiologie

    Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study

    BARBUT F, DAY N, BOUÉE S, YOUSSOUF A, GRANDVOINNET L, LALANDE V, COUTURIER J, ECKERT C

    Clin Microbiol Infect ; 2019;25(5):588-594

  • Pharmaco-Epidémiologie

    Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation

    HANON O, VIDAL JS, PISICA-DONOSE G, ORVOËN G, DAVID JP, CHAUSSADE E, CAILLARD L, DE JONG LW, BOULLOCHE N, VINSONNEAU U, BOUEE S, KROLAK-SALMON P, FAUCHIER L, JOUANNY P, SACCO G, BELLARBRE F, BELMIN J, PUISIEUX F, LILAMAND M, PAILLAUD E, BOUREAU AS ; SAFIR STUDY GROUP

    Heart ; 2020(Online)

  • Pharmaco-Epidémiologie

    Mepolizumab in a population with severe osinophilic asthma and corticosteroid dependence: results from French early access programme

    TAILLE C, CHANEZ P, DEVOUASSOUX G, DIDIER A, PISON C, GARCIA G, CHARRIOT J, BOUEE S, GRUBER A, PRIBIL C, BOURDIN A, HUMBERT M.

    Eur Respir J ; 2020;55(6)

  • Pharmaco-Epidémiologie

    Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in EGFR-mutated non-small-cell lung cancer: a real life study

    GIRARD N, MORO-SIBILOT D, BOUEE S, EMERY C, TORRETON E, LE LAY K, LUCIANI L, MARITAZ C, CHOUAID C.

    Future Oncol ; 2020;16(16),1115-1124

  • Pharmaco-Epidémiologie

    Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study

    DINH A, LE MONNIER A, EMERY C, ALAMI S, TORRETON É, DUBURCQ A, BARBIER F.

    Eur J Clin Microbiol Infect Dis ; 2019;38(7):1297-1305

  • Pharmaco-Epidémiologie

    Short-term effect of severe hypoglycaemia on glycaemic control in the Diabetes Control and Complications Trial

    MOUTAIROU A, ROUSSEL R, CHARBONNEL B, EL BOUSTANY R, NICOLAS A, LEYE A, MOHAMMEDI K, MARRE M, DETOURNAY B, POTIER L.

    Diabetes Metab ; 2017;43(2):187-190

  • Pharmaco-Epidémiologie

    [Which ovarian stimulation to which women: The polycystic ovary syndrome (PCOS)]

    MERVIEL P, BOUEE S, MENARD M, LE MARTELOT MT, ROCHE S, LELIEVRE C, CHABAUD JJ, JACQ C, DRAPIER H, BEAUVILLARD D.

    Gynecol Obstet Fertil Senol ; 2017;45(11):623-631